Highlights of Recommendation: â¦ Candesartan cilexetil (Atacand) 32mg tablet is a new dosage strength added to the current product line. â¦ Three other strengths of candesartan cilexetil - 4mg tablet, 8mg tablet, and 16mg tablet-are already listed on the Ontario Drug Benefit Formulary as General Benefits. In addition, two open-labelled multicentre clinical studies found that candesartan cilexetil 32mg produced a mean reduction in systolic and diastolic pressure ranging from 18.7 to 20.5 mm Hg and 13.1 to 13.2mm Hg, respectively.
The Single Loss Expectancy (SLE) is the cost of a single loss. SLE is the Asset Value (AV) times the Exposure Factor (EF). In our case, SLE is $25,000 (Asset Value) times 100% (Exposure Factor), or $25,000.
In many loss reserve analyses, the projections tend to creep up or. down(mainly up) from one evaluation to the next. One standard. explanation is that the change in ultimate loss was due to. âunexpected adverse development.â This explanation is valid once. or twice, but is not valid year after year.